Table 3.
Nationally approved antidepressants in selected SSA countries by their respective drug regulatory authorities.
| Country | Approved Antidepressants | References |
|---|---|---|
| Botswana | Amitriptyline, fluoxetine, trimipramine | (Ministry of Health, 2012) |
| Ethiopia | Fluoxetine, amitriptyline | (Ethiopia Food Medicine and Healthcare Administration and Control Authority, 2010) |
| Ghana | Fluoxetine, sertraline, citalopram, imipramine, amitriptyline | (Ministry of Health, 2017) |
| Kenya | Amitriptyline, fluoxetine, venlafaxine | (Ministry of Health) |
| Nigeria | Fluoxetine, amitriptyline | (Federal Ministry of Health, 2018) |
| South Africa | Fluoxetine, citalopram, amitriptyline | (National Department of Health, 2015) |
| Sudan | Imipramine, sertraline | (Federal Ministry of Health, D. G. of P. 2014) |
| Uganda | Amitriptyline, fluoxetine, imipramine | (Ministry of Health) |
| Zambia | Sertraline, clomipramine, fluoxetine | (Zambia Ministry of Health, 2019) |
| Malawi | Amitriptyline, fluoxetine, | (Ministry of Health, (Government of Malawi), 2015) |
| Rwanda | Amitriptyline, fluoxetine, flupenthixol | (MINISTERE DE LA SANTE REPUBLIQUE DU RWANDA, 2010) |
| Zimbabwe | Amitriptyline, fluoxetine, sertraline, imipramine, citalopram, venlafaxine, duloxetine, mianserin | (The National Medicine and Therapeutics Policy Advisory Committee, 2015) |